Over 10 years experience of Traceability Solutions
By pharmatrax
Category: Technoloy
No Comments 3D tissue printing startup Prellis Biologics has assembled $8.7 million in new funding alongside positive news from the first transplantation of its vascular tissue scaffolds…
By pharmatrax
Category: Technoloy
No Comments 3D printers have long captured the imagination, enabling almost anyone (with the right equipment and design files) to create almost any inanimate object they can…
By pharmatrax
Category: Technoloy
No Comments What are the trends shaping the successful delivery of patient centric services? The pharmaceutical industry is evolving rapidly and as times change, so do the…
By pharmatrax
Category: Technoloy
No Comments The biopharma industry loses approximately $35 billion annually as a result of failures in temperature-controlled logistics, according to IQVIA Institute for Human Data Science. The…
By pharmatrax
Category: Technoloy
No Comments The future of the global economy is uncertain. Growth is slowing and productivity is at a record low. Yet – on a positive note –…
By pharmatrax
Category: Technoloy
No Comments The health sector is going through rapid and radical transformation and new technologies are redesigning the way healthcare is delivered, and even conceived of, thanks…
By pharmatrax
Category: Technoloy
No Comments Enterprise Europe Network explains how collaboration is the key to innovation in pharma and how businesses should collaborate to grow. Successful business in the pharmaceutical industry depends…
By pharmatrax
Category: Technoloy
No Comments Firms ramping up innovation efforts in new sectors like high-quality drugs and biologics As China moves forward from being the world’s manufacturing powerhouse to an…
By pharmatrax
Category: Technoloy
No Comments By turning molecular structures into sounds, researchers gain insight into protein structures and create new variations. Want to create a brand new type of protein…
By pharmatrax
Category: Technoloy
No Comments Alphabet Inc. (NASDAQ:GOOG) managers are incubating vibrant new businesses in pharma and tech This might seem a particularly bad time to be investing in big…